Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery

Anesthesiology

Volumn 92, Issue 3, 2000, Pages 646-656

  Lamy, Maurice L ^a   Daily, Elaine K ^b   Brichant, Jean François ^c   Larbuisson, Robert P ^a   Demeyere, Roland H ^d   Vandermeersch, Eugene A ^d   Lehot, Jean Jacques ^e   Parsloe, Malcolm R ^f   Berridge, John C ^f   Sinclair, Colin J ^g   Baron, Jean François ^h   Przybelski, Robert J ⁱ  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Cardiovascular Research and Education Consulting   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e LOUIS PRADEL HOSPITAL   (France)

^f LEEDS GENERAL INFIRMARY   (United Kingdom)

^g ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^h HÔPITAL BROUSSAIS   (France)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Blood substitute; Erythrocyte substitute; Oxygen carrier; Oxygen carrying compounds

Indexed keywords

DIASPIRIN CROSSLINKED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; FEMALE; HEART SURGERY; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT INDICATION;

EID: 0034054118     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200003000-00007     Document Type: Article

References (33)

1. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP IV, Petersen LR: Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995; 333:1721-5
2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334:1685-90
3. Klein HG: Allogeneic transfusion risks in the surgical patient. AmJ Surg 1995; 170:21.S-6.S
4. Edna TH, Bjerkeset T: Association between blood transfusion and infection in injured patients. J Trauma 1992; 33:659-61
5. Gottlieb T: Hazards of bacterial contamination of blood products. Anaesth Intensive Care 1993; 21:20-3
6. Rosengart TK, Helm RE, DeBois WJ, Garcia N, Krieger KH, Isom OW: Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: Implications for a "bloodless" surgical technique. J Am Coll Surg 1997; 184: 618-29
7. Azari M, Catarello K, Burhop K, Camacho T, Ebeling A, Estep T, Guzder S, Krause K, Marshall T, Rohn K, Sarajari R: Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb) for viral inactivation - effect of crosslinking Art Cells Blood Subs Immobil Biotech 1997; 25:521-6
8. Estep TN, Bechel MK, Miller TJ, Bagdasarian A: Virus inactivation in hemoglobin by heat, Blood substitutes. Edited by Chang TMS. New York, Marcel Dekker, 1989, pp 129-34
9. Birnbaum ML, Lipman J, Garrioch M, Daily E, Przybelski R: Diaspirin cross-linked hemoglobin (DCLHb) vs. blood in acutely anemic patients. Intensive Care Med 1997; 23(suppl 1):S85
10. Malcolm DS, Hamilton I, Schultz S, Cole F, Burhop K: Characterization of the hemodynamic response to intravenous diaspirin cross-linked hemoglobin solution in rats. Art Cells Blood Subs Immobil Biotech 1994; 22:91-107
11. Cohn SM, Farrell TJ: Diaspirin cross-linked hemoglobin resuscitation of hemorrhage: Comparison of a blood substitute with hypertonic saline and isotonic saline. J Trauma 1995; 39(2):210-7
12. Sharma AC, Singh G, Gulati A: Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 1995; 265(38):1379-88
13. Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colburn WA: Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution (DCLHb™). Crit Care Med 1996; 24:1993-2000
14. Swan SK, Halstenson CE, Collins AJ, Colburn WA, Blue J, Przybelski RJ: Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. Am J Kidney Dis 1995; 26:918-23
15. Garrioch MR, Larbuisson R, Brichant JF, Lamy M, Daily E, Przybelski R: The hemodynamic effects of diaspirin cross-linked hemoglobin (DCLHb) in the operative setting. Crit Care Med 1996; 24:A39
16. Rhea G, Bodenham AR, Mallik A, Daily EK, Przybelski RJ: Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med 1997; 25:1480-8
17. Powell CC, Schultz SC, Bums DG, Drucker WR, Malcolm DS: Resuscitation with diaspirin-cross-linked hemoglobin (DCLHb) restores subcutaneous oxygen tension as well as blood in rats. Surgical Forum 1993; 44:40-2
18. Przybelski RJ, Malcolm DS, Burris DG, Winslow RM: Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med 1992; 117:143-51
19. 2). J Biol Chem 1986; 261:9929-37
20. Przybelski RJ, Daily EK: The pressor/perfusion effect of diaspirin cross-linked hemoglobin (DCLHb), Yearbook of Intensive Care and Emergency Medicine. Edited by Vincent JL. Heidelberg, Springer-Verlag, 1994, pp 252-63
21. Stover EP, Siegel LC, Parks R, Levin J, Body SC, Maddi R, D'Ambra MN, Mangano DT, Spiess BD: Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines. ANESTHESIOLOGY 1998; 88:327-33
22. Spence RK for the Blood Management Practice Guidelines Conference: Surgical red blood cell transfusion practice policies. Am J Surg 1995; 170(6A):3.S-15.S
23. Wedgewood JJ, Thomas JG: Perioperative haemoglobin: An overview of current opinion regarding the acceptable level of haemoglobin in the peri-operative period. EurJ Anaesthesiol 1996; 13:316-24
24. Goodnough LT, Despotis GJ, Hogue CW, Ferguson TB: On the need for improved transfusion indicators in cardiac surgery. Ann Thorac Surg 1995; 60:473-80
25. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E, The Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. New Engl J Med 1999; 340: 409-17
26. Carson JL, Spence RK, Poses RM, Bonavita G: Severity of anaemia and operative mortality and morbidity. Lancet 1988; 2:727-29
27. Viele MK, Weiskopf RB, Fisher D: Recombinant human hemoglobin does not affect renal function in humans: Analysis of safety and pharmacokinetics. ANESTHESIOLOGY 1997; 86:848-58
28. Hughes GS, Antal EJ, Locker PK, Francom SF, Adams EJ, Jacobs EE: Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med 1996; 24:756-64
29. Kasper SM, Walter M, Grüne F, Bischoff A, Erasmi H, Buzello W: Effects of hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996; 83:921-7
30. Sharma AC, Singh G, Gulati A: Role of NO mechanism in cardiovascular effects of diaspirin crosslinked hemoglobin in anesthetized rats. AmJ Physiol 1995; 269:H1379-488
31. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122:301-8
32. Gulati A, Rebello S: Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 1994; 124:125-33
33. 2 release by inositol hexaphosphate-loaded erythrocytes. Proc Natl Acad Sci USA 1987; 84:6894-8